Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: John M. McCann who wrote (1586)	6/10/1998 8:43:00 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Jack, Thanks for the update. I think the presentation was best cancelled regardless of Dr. Naughton's illness, as ATIS has already stated several times for those who spoke with them. I do disagree with one of the areas the analysts raised as concerns ....the part about ORG's poor performance after approval. ORG had a nice run well in advance of the approval, something ATIS hasn't had. Actually, ATIS dropped along the way as a result of the letter, etc. while ORG was running up. This may have affected people who were simply watching the daily movement without monitoring the historical aspects however. The analysts are correct that this may have affected share price in the short haul, but this is the very reason there is so much room for upward movement with good news at this point. I also agree about the internet being a source for many people looking for information, and the complaints asking for management's heads, etc. affect many, although typically without any merit except for concerns about the horrible stock price. Of interest, one person from IR spoke of someone complaining to ATIS recently, wanting them to fire the person in charge of setting the stock price..... :) it's a crapshoot, but some research is needed, especially in this industry. I very much appreciate your research and update. Regards, Marshall